bevacizumab,atezolizumab
roche
['hcc', 'atezo', ' bev ', 'imbrave 050']
imbrave 050 presented at #aacr2023. adjuvant atezo plus bev improves rfs in pts with hcc who have undergone resection or ablation. potentially practice changing! #aacr23 #aacr2023 #research #cancerresearch 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"